Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia.
about
Muscle dysfunction in cancer patientsMolecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Cancer cachexia: impact, mechanisms and emerging treatmentsEicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexiaInflammation based regulation of cancer cachexiaMuscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouseThe regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexiaSarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.Cancer cachexia prevention via physical exercise: molecular mechanisms.Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexiaRoles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.Motor protein function in skeletal abdominal muscle of cachectic cancer patients.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.A leucine-rich diet modulates the tumor-induced down-regulation of the MAPK/ERK and PI3K/Akt/mTOR signaling pathways and maintains the expression of the ubiquitin-proteasome pathway in the placental tissue of NMRI mice.Molecular mechanism of sarcopenia and cachexia: recent research advances.Effects on the ubiquitin proteasome system after closed soft-tissue trauma in rat skeletal muscle.Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2.Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice.Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
P2860
Q26822365-0548E13D-4EBB-41CD-9469-C7B94B0610BEQ28068034-B863F6A1-244D-475F-95BD-C87A4F9FC827Q28384479-8316B2A5-7C9C-4CDE-A691-7F27FBBA2CB7Q28483912-C11F5764-5230-40E8-BB46-FC3F165A05FBQ33615916-01D133F5-1964-487D-BDD7-F26241D60498Q33839434-2042F43C-D498-4616-9623-567977AC137BQ34031423-65045096-F9C5-40F5-8316-4E035AB19702Q35958613-C3FE0EE9-25D2-4A2F-B1F3-C51693A3DFD7Q36028202-9D60A2BA-DE3A-4548-B297-22B6275E2A5FQ36934986-CAAC9BEE-0924-4458-B186-850325F519BCQ37016738-C31BB318-850F-49EB-B9A7-4BCC32317B36Q37019253-84D6CEF5-29B5-47CE-8D24-439B0FA6D3FFQ37562334-26E74746-2926-424D-903B-E22A4F12A2BDQ38557891-42A92C5B-1799-401D-9293-85F54357ACA0Q38940463-5280A662-E351-4360-A2FA-0291B1431D37Q39094397-0F5EF43C-0BBC-4A64-99B7-304DE8EC6524Q40056067-C2B69B67-C033-4A31-91B3-2655FD9171C0Q40208275-E3F205D2-840C-4E3C-847B-28F8DDB14398Q41874017-B3A762F5-6D13-41D3-BF8F-0ACE6AFE211DQ59127762-68CF177B-DBFA-4157-BEE9-61954D937F44
P2860
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia.
description
2005 nî lūn-bûn
@nan
2005 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Expression of the ubiquitin-pr ...... experimental cancer cachexia.
@en
Expression of the ubiquitin-pr ...... experimental cancer cachexia.
@nl
type
label
Expression of the ubiquitin-pr ...... experimental cancer cachexia.
@en
Expression of the ubiquitin-pr ...... experimental cancer cachexia.
@nl
prefLabel
Expression of the ubiquitin-pr ...... experimental cancer cachexia.
@en
Expression of the ubiquitin-pr ...... experimental cancer cachexia.
@nl
P2093
P2860
P356
P1476
Expression of the ubiquitin-pr ...... n experimental cancer cachexia
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602780
P407
P577
2005-10-01T00:00:00Z